Adient (ADNT) CEO Insider Sale — 12,000 Shares at $22.77 (Form 4)

Jerome J. Dorlack, who is listed as President and CEO and a director of Adient plc (ADNT), reported a sale of ordinary shares on 08/07/2025.

Rhea-AI Filing Summary

Jerome J. Dorlack, who is listed as President and CEO and a director of Adient plc (ADNT), reported a sale of ordinary shares on 08/07/2025. The filing discloses a disposition of 12,000 ordinary shares at a weighted average price of $22.77 per share, with sale prices ranging from $22.76 to $22.90. Following the reported transaction, the reporting person beneficially owned 441,025 shares on a direct basis. No derivative securities were reported on this form. The Form 4 was signed by an attorney-in-fact, Brett L. Eilander, on 08/08/2025.

Insights

Securities Analyst

TL;DR: Routine insider disposition disclosed; details include 12,000 shares sold at a $22.77 weighted average and 441,025 shares remain beneficially owned.

The Form 4 reports a direct sale transaction by Jerome J. Dorlack, identified as both President and CEO and a director of Adient plc. The filing provides clear trade details: 12,000 ordinary shares sold on 08/07/2025, weighted average price $22.77, with prices between $22.76 and $22.90. Post-transaction direct beneficial ownership is listed as 441,025 shares. No derivatives are listed. From a disclosure and market transparency perspective, the form supplies the essential facts investors typically use to update insider-trading records.

Corporate Governance Expert

TL;DR: Insider sale disclosed by CEO/director; the filing documents the transaction and remaining direct holdings without reporting derivatives.

This Form 4 documents compliance with Section 16 reporting requirements for an officer/director. It shows a sale executed on 08/07/2025 and was executed by an attorney-in-fact, with the Form signed on 08/08/2025. The filing lists the precise share counts and price range and reports no derivative positions. For governance monitoring, the filing is complete in its factual disclosures; it does not, by itself, indicate any change in control or material corporate action.

Insider Trade Summary

Net Seller: 12,000 shares

Net Sell 1 txn

Insider Dorlack Jerome J.

Role President and CEO

Sold 12,000 shs ($273K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	12,000	$22.77	$273K

Holdings After Transaction: Ordinary Shares — 441,025 shares (Direct)

Footnotes (1)

1. F1. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $22.76 to $22.90. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Jerome J. Dorlack report on the Form 4 for ADNT?

The report discloses a sale of 12,000 ordinary shares of Adient plc executed on 08/07/2025.

At what price were the ADNT shares sold according to the Form 4?

The shares were sold at a weighted average price of $22.77, with individual sale prices ranging from $22.76 to $22.90.

How many ADNT shares does Jerome J. Dorlack beneficially own after the reported sale?

Following the reported transaction, the filing shows 441,025 shares beneficially owned on a direct basis.

Did the Form 4 for ADNT report any derivatives or option transactions?

No. Table II (derivative securities) contains no reported transactions or holdings.

Who signed the Form 4 filing for Jerome J. Dorlack?

The Form 4 was signed by attorney-in-fact Brett L. Eilander on 08/08/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/08/2025 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dorlack Jerome J.

(Last) (First) (Middle)

49200 HALYARD DRIVE

(Street)

PLYMOUTH MI 48170

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Adient plc [ ADNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/07/2025		S		12,000	D	$22.77(1)	441,025	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $22.76 to $22.90. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Brett L. Eilander, Attorney-in-fact for Jerome J. Dorlack	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.